Compounders Research Compare

Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Biotechnology · Norwood, MA

$5.67-0.18 (-3.08%)

Delayed quote: Oct 6, 2026, 10:20 AM EDT

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Norwood, MA

36 employees

www.corbuspharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Yuval Cohen

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T14:21:21.747Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:21:21.747Z.

Quote observation: 2026-10-06T14:20:18.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -6.48
Quote price: 5.67

FMP input reference: 26be04fabca1f5abb96b6b094ab833c4d2e2f23bc88365d6eea621c26c981704

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CRBP Earnings Yield Metrics

EARNINGS YIELD

N/A

CRBP Competitors' Earnings Yield

Corbus Pharmaceuticals Holdings, Inc.

Current

Market Cap

$105.05M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Definitive Healthcare Corp.

Market Cap

$104.82M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Immunic, Inc.

Market Cap

$106.73M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cumberland Pharmaceuticals Inc.

Market Cap

$110.73M

Earnings Yield

N/A

TTM Avg

0.32%

3Y Avg

0.91%

5Y Avg

2.50%

Black Diamond Therapeutics, Inc.

Market Cap

$106.58M

Earnings Yield

N/A

TTM Avg

9.36%

3Y Avg

9.36%

5Y Avg

9.36%

Foghorn Therapeutics Inc.

Market Cap

$108.33M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aardvark Therapeutics, Inc. Common Stock

Market Cap

$109.20M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

The Joint Corp.

Market Cap

$102.00M

Earnings Yield

3.71%

TTM Avg

2.61%

3Y Avg

2.26%

5Y Avg

1.70%

Apyx Medical Corporation

Market Cap

$109.91M

Earnings Yield

N/A

TTM Avg

26.36%

3Y Avg

26.36%

5Y Avg

26.36%

BGM Group Ltd.

Market Cap

$111.84M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	$105.05M	N/A	N/A	N/A	N/A
Definitive Healthcare Corp. (DH)vs ›	$104.82M	N/A	N/A	N/A	N/A
Immunic, Inc. (IMUX)vs ›	$106.73M	N/A	N/A	N/A	N/A
Cumberland Pharmaceuticals Inc. (CPIX)vs ›	$110.73M	N/A	0.32%	0.91%	2.50%
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$106.58M	N/A	9.36%	9.36%	9.36%
Foghorn Therapeutics Inc. (FHTX)vs ›	$108.33M	N/A	N/A	N/A	N/A
Aardvark Therapeutics, Inc. Common Stock (AARD)vs ›	$109.20M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.00M	3.71%	2.61%	2.26%	1.70%
Apyx Medical Corporation (APYX)vs ›	$109.91M	N/A	26.36%	26.36%	26.36%
BGM Group Ltd. (BGM)vs ›	$111.84M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics